Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-03

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Current study evaluates the use of the improved Basophil Activation Test (BAT) in the diagnostics of IgE-mediated allergy to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment

NCT01520181

Beta-lactam Allergy

COMPLETED NA

Basophile Activation Testing (BAT) in Hazelnut Allergy (Hazelnut BAT Study)

NCT03079206

Food Allergy

COMPLETED NA

Monitoring Allergen Immunotherapy in Allergic Rhinitis

NCT05621356

Immunotherapy Rhinitis, Allergic Treatment Outcome

UNKNOWN

Safety Study of Anti-IgE Immunotherapy in Allergic Patients

NCT00439621

Allergy

COMPLETED PHASE2

Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTest

NCT03820154

Allergic Rhinitis Allergic Asthma Allergic Conjunctivitis +1 more

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Current study evaluates the use of the improved Basophil Activation Test (BAT) in the diagnostics of IgE-mediated allergy to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs). Among commonly used CD63/CD203c markers, newly proposed molecules, such as CD69, CD107a, CD164, CD13, CD11b and CD300a will be assayed. Results obtained together with the other clinical data will be used to calculate sensitivity and specificity of the method.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Allergy Antibiotic Allergy NSAID-Induced Anaphylactoid Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with drug allergy

Patients with drug allergy to antibiotics or NSAIDs

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* suspected allergy to antibiotics or NSAIDs in the last 1 year.

Exclusion Criteria

* autoimmune diseases;
* HIV;
* hepatitis B/C;
* other acute or chronic infectious diseases;
* malignant neoplasms;
* leukemia;
* other severe acute or chronic intercurrent diseases;
* pregnancy/lactation;
* refuse of patient to participate in the trial.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No